From policemen to policies: what is the future for 2-h glucose? The Kelly West Lecture, 2000

Diabetes Care. 2001 Nov;24(11):1945-50. doi: 10.2337/diacare.24.11.1945.

Abstract

Objective: To describe the characteristics and vital prognosis of men with diabetes diagnosed by one fasting plasma glucose (FPG) concentration > or =7.0 mmol/l, with diabetes diagnosed by one isolated postchallenge hyperglycemia (IPH) (FPG <7.0 mmol/l and a 2-h plasma glucose concentration > or =11.1 mmol/l), or with impaired glucose tolerance (IGT).

Research design and methods: This study involved a cohort of 6,881 Caucasian nondiabetic men from the Paris Prospective Study, aged 44-55 years, who were followed for cause of death for 20 years.

Results: Diabetes was diagnosed in 4.3% of the men (1.0% diabetes diagnosed by IPH), and IGT was diagnosed in 9% of the men. At baseline, the men with diabetes diagnosed by IPH had a lower cardiovascular risk profile than those with diabetes diagnosed by FPG, as did the men with IGT and a normal fasting glucose level (<6.1 mmol/l, IGT and normal fasting glucose), compared with men with impaired fasting glucose (6.1-6.9 mmol/l, IGT and impaired fasting glucose [IFG]). At 20 years of follow-up, all-cause and cancer death rates were higher in men with diabetes diagnosed by IPH than in men with diabetes diagnosed by FPG (55 vs. 44%, P < 0.1 and 31 vs. 17%, P < 0.01, respectively) but were not significantly different for coronary causes (6 vs. 11%). Men with IGT and normal fasting glucose also had significantly higher cancer death rates than men with IGT and IFG.

Conclusions: The most likely explanation for the high cancer and low coronary death rates is that men with diabetes diagnosed by IPH consumed alcohol; the men in this study drank 49 g of pure alcohol on average per day, equivalent to 0.6 l of wine. If these results are confirmed by other prospective studies, screening subjects for isolated postchallenge hyperglycemia may not be worthwhile.

Publication types

  • Lecture

MeSH terms

  • Adult
  • Blood Glucose / metabolism*
  • Cardiovascular Diseases / epidemiology
  • Cause of Death
  • Cohort Studies
  • Coronary Disease / mortality
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus / epidemiology*
  • Diabetes Mellitus / mortality
  • Fasting
  • Follow-Up Studies
  • Glucose Tolerance Test*
  • Humans
  • Hyperglycemia / blood
  • Hyperglycemia / epidemiology*
  • Insulin / blood
  • Male
  • Middle Aged
  • Neoplasms / mortality
  • Paris / epidemiology
  • Police*
  • Prevalence
  • Prospective Studies
  • Risk Factors
  • Survival Rate
  • Time Factors
  • White People

Substances

  • Blood Glucose
  • Insulin